Old Web
English
Sign In
Acemap
>
authorDetail
>
Michael Palfreyman
Michael Palfreyman
Drug
Partial agonist
Medicine
Psychiatry
Randomized controlled trial
3
Papers
166
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Encenicline, a Selective α7 Nicotinic Receptor Partial Agonist, in Single Ascending-dose and Bioavailability Studies
2015
Clinical Therapeutics
Ann J. Barbier
Martijn Hilhorst
Andre van Vliet
Peter J. Snyder
Michael Palfreyman
Maria Gawryl
Nancy Dgetluck
Monica Massaro
Renger G. Tiessen
W Timmerman
Dana Hilt
Show All
Source
Cite
Save
Citations (41)
Normalizing effects of EVP-6124, an α-7 nicotinic partial agonist, on event-related potentials and cognition: a proof of concept, randomized trial in patients with schizophrenia.
2014
Journal of Psychiatric Practice
Sheldon H. Preskorn
Maria Gawryl
Nancy Dgetluck
Michael Palfreyman
Lance O. Bauer
Dana Hilt
Show All
Source
Cite
Save
Citations (106)
Enzymes as Targets for Drug Design
1990
Michael G. Palfreyman
Michael Palfreyman
Walter Lovenberg
Peter P. McCann
Show All
Source
Cite
Save
Citations (19)
1